Full Credit to All Underwriters, Ranked by After-Market Performance*# Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) After-Market Performance (Average) 1 ThinkEquity LLC (0/1) +128% 2 Goldman, Sachs & Co. (1/1) +89% 3 BMO Capital Markets (2/3) +71% 4 Wedbush PacGrow Life Sciences (0/3) +57% 5 Needham & Co. (0/4) +52% 6 Lazard Capital Markets (1/3) +45% 7 Piper Jaffray (1/1) +43% 8 Bank of America Merrill Lynch (3/3) +33% 9 J.P. Morgan Securities (3/3) +28% 10 Citigroup Global
Full Credit to Lead Underwriter, Ranked by After-Market Performance*# Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) After-Market Performance (Average) 1 BMO Capital Markets (2/3) +93% 2 Goldman, Sachs & Co. (1/1) +89% 3 Lazard Capital Markets (1/3) +58% 4 Piper Jaffray (1/1) +43% 5 Bank of America Merrill Lynch (3/3) +33% 6 J.P. Morgan Securities (3/3) +28% 7 Citigroup Global Markets (including citibank) (3/3) +26% 8 Cowen & Co. (3/6) +26% 9 Morgan Stanley (1/1) +26% 10 Leerink
Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) Gross Proceeds (M) 1 Cowen & Co. (3/6) $368.00 2 Leerink Swann (4/5) $346.51 3 Bank of America Merrill Lynch (3/3) $263.98 4 Needham & Co. (0/4) $252.61 5 J.P. Morgan Securities (3/3) $232.85 6 BMO Capital Markets (2/3) $224.00 7 Wedbush PacGrow Life Sciences (0/3) $215.00 8 Lazard Capital Markets (1/3) $195.15 9 Citigroup Global Markets (including citibank) (3/3) $189.00 10
Full Credit to Lead Underwriter, Ranked by Gross Proceeds* Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) Gross Proceeds (M) 1 Leerink Swann (4/4) $265.5 2 Citigroup Global Markets (including citibank) (3/3) $189.0 3 J.P. Morgan Securities (2/2) $151.9 4 Cowen & Co. (2/5) $115.0 5 Morgan Stanley (1/1) $87.0 6 Bank of America Merrill Lynch (1/2) $77.6 7 Credit Suisse (1/1) $77.6 8 UBS Investment (1/1) $63.3 9 Stifel Nicolaus Weisel (1/2) $58.0 10 Piper Jaffray (1/1) $50.0 * The
Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) Gross Proceeds (M) 1 Cowen & Co. (2/5) $317.0 2 Leerink Swann (4/4) $265.5 3 Citigroup Global Markets (including citibank) (3/3) $189.0 4 Bank of America Merrill Lynch (1/2) $177.7 5 Oppenheimer & Co. (0/2) $163.4 6 J.P. Morgan Securities (2/2) $151.9 7 Needham & Co. (0/2) $115.5 8 Stifel Nicolaus Weisel (1/2) $108.0 9 Morgan Stanley (1/1) $87.0 10 BMO Capital Markets (0/1) $86
Full Credit to Lead Underwriter, Ranked by After-Market Performance*# Rank Underwriter (IPOs as Lead/IPOs as Lead or Co-Manager) After-Market Performance (Average) 1 Piper Jaffray (1/1) 131% 2 J.P. Morgan Securities (2/2) 99% 3 Citigroup Global Markets (including citibank) (3/3) 51% 4 Stifel Nicolaus Weisel (1/2) 29% 5 Cowen & Co. (2/5) 18% 6 Leerink Swann (4/4) 9% 7 Morgan Stanley (1/1) 5% 8 Bank of America Merrill Lynch (1/2) 4% 9 Credit Suisse (1/1) 4% 10 UBS Investment (1/1) -6% * The
Full Credit to All Underwriters, Ranked by After-Market Performance*# Rank Underwriter Offerings As Lead Offerings as Co-Manager After-Market Performance 1 Bank of America Merrill Lynch 1 1 31% 2 Jefferies & Co
Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Co-Manager Gross Proceeds (M) 1 Leerink Swann 1 3 $311.75 2 Robert W. Baird 0 3 $265.60 3 Stifel Nicolaus Weisel 2 3 $242.60 4 Canaccord Genuity 1 3 $233.10 5 Cowen & Co
Full Credit to Lead Underwriter, Ranked by After-Market Performance*# Rank Underwriter Offerings As Lead Offerings as Lead or Co-Manager After-Market Performance (Average) 1 Bank of America Merrill Lynch 1 1 31% 2 Jefferies & Co
Full Credit to Lead Underwriter, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Lead or Co-Manager Gross Proceeds (M) 1 Stifel Nicolaus Weisel 2 3 $188.60 2 Piper Jaffray 3 3 $168.40 3 Credit Suisse 1 1 $139.10 4 J.P. Morgan Securities 1 1 $139.10 5 Canaccord Genuity 1 3 $139.00 6 Bank of America Merrill Lynch 1 1 $92.00 7 Jefferies & Co
Full Credit to All Underwriters, Ranked by After-Market Performance*# Rank Underwriter Offerings As Lead Offerings as Co-Manager After-Market Performance 1 Wedbush PacGrow Life Sciences 0 1 +80% 2 RBC Capital Markets 1 2 +64% 3 Bank of America Merrill Lynch 1 1 +44% 4 Jefferies & Co
Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Co-Manager Gross Proceeds (M) 1 RBC Capital Markets 1 2 $178.25 2 Cowen & Co
Full Credit to Lead Underwriter, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Lead or Co-Manager Gross Proceeds (M) 1 Piper Jaffray 3 3 $168.4 2 Bank of America Merrill Lynch 1 1 $92 3 Jefferies & Co...1 3 $49.5 10 JMP Securities 1 2 $49.5 11 Stifel Nicolaus Weisel 1 2 $49.5 12 Barclays Capital 1 1 $42 13 Lazard Capital Markets 1 1 $40.25 14 Maxim Group LLC 1 1 $12.84 15 Roth
Full Credit to Lead Underwriter, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Lead or Co-Manager Gross Proceeds (M) 1 J.P. Morgan Securities 3 3 $505.73 2 Morgan Stanley 3 3 $505.73 3 Credit Suisse 2 2 $288.05 4 Citigroup Global Markets 3 3 $188.95 5 Leerink Swann 4 5 $183.5 6 Deutsche Bank Securities 2 3 $113...1 1 $54.0 10 UBS Investment Bank 1 1 $54.0 11 Piper Jaffray 1 4
Full Credit to All Underwriters, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Co-Manager Gross Proceeds (M) 1 J.P. Morgan Securities 3 3 $505.73 2 Morgan Stanley 3 3 $505.73 3 Piper Jaffray 1 4 $326.23 4 Deutsche Bank Securities 2 3 $313.13 5 Credit Suisse 2 2 $288.05 6 Wedbush PacGrow Life Sciences 0 2 $282.9 7 Leerink Swann 4 5 $273.23 8 Cowen & Co
Full Credit to Lead Underwriter, Ranked by Gross Proceeds* Rank Underwriter Offerings As Lead Offerings as Lead or Co-Manager Gross Proceeds (M) 1 J.P. Morgan Securities 3 3 $505.73 2 Morgan Stanley 3 3 $505.73 3 Credit Suisse 2 2 $288.05 4 Citigroup Global Markets 3 3 $188.95 5 Leerink Swann 4 5 $183.5 6 Deutsche Bank Securities 2 3 $113.13 7 National Securities 1 1 $56.0 8 Wells Fargo 1 1 $56.0 9
excellent track record on manufacturing and FDA relations deserves and appears to be getting full credit